Segment and Geographic Information (Tables)

6 Months Ended

Jun. 30, 2012

Product revenue by product group is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011		2012		2011
Orthobiologics	$	10,903,364	$	9,763,597	$	21,020,209	$	17,799,893
Dermal		155,735		799,605		657,051		1,388,759
Ophthalmic		5,299,732		2,584,820		6,623,726		3,482,629
Surgical		1,464,505		1,566,026		2,448,133		2,679,755
Veterinary		1,058,941		700,633		1,746,486		1,123,804
	$	18,882,277	$	15,414,681	$	32,495,605	$	26,474,840

Product Revenue by Geographic Location and Percentage of Total Product Revenue

Product revenue by geographic location in total and as a percentage of total product revenue, for the three and six months ended June 30, 2012 and 2011 are as follows:

	Three Months Ended June 30,
	2012					2011
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	16,011,667		85	%	$	11,594,988		75	%
Europe		1,521,552		8	%		2,604,021		17	%
Other		1,349,058		7	%		1,215,672		8	%
Total	$	18,882,277		100	%	$	15,414,681		100	%

	Six Months Ended June 30,
		2012					2011
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	26,401,712		81	%	$	19,938,102		75	%
Europe		3,677,281		11	%		4,637,219		18	%
Other		2,416,612		8	%		1,899,519		7	%
Total	$	32,495,605		100	%	$	26,474,840		100	%

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details